STAT

Opinion: Medicare for All should guarantee coverage for oral health

With multiple "Medicare for All" proposals now on the table, it's time to fix past mistakes that segregated care for #oralhealth from the rest of the body.
Hundreds of people without medical insurance get free dental services from volunteer dentists and dental technicians in 2010 at the Remote Area Medical clinic inside the Los Angeles Sports Arena in Los Angeles.

With multiple “Medicare for All” proposals now circulating in Congress, opportunities arise to fix past mistakes that have segregated care for our mouths and teeth from the rest of our bodies. Polling shows that today’s universal coverage efforts are driven largely by public outcry that people can’t afford the health care they need to be happy, healthy, and successful. As this robust discussion continues, it’s time to include comprehensive dental care as a standard part of health coverage. No plan can fully address consumers’ concerns without it.

Regardless of than any other aspect of health care — even though oral health is a crucial part of overall well-being. Untreated dental disease is linked to . It can raise the risk for heart disease, make diabetes more difficult to manage, and may be linked to pregnancy complications such as premature birth. In childhood, tooth decay can harm healthy development and lead to , limiting students’ potential.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks